March 2026 | ENDO Lab & Medical Systems
Clinical Lab Newsletter
Innovation, Regulation, and Strategic Trends in Molecular Testing & Remnant Sample Research
1
LDT Regulation Reset. Pressure Off for Now
The FDA’s 2024 LDT rule has officially been rolled back, reverting oversight to the pre-2024 framework.
What this means:
- Immediate regulatory pressure has eased
- CLIA, CAP, and internal validation remain your foundation
- This is a pause, not the end of the conversation
Smart labs are using this window to strengthen validation frameworks before the next wave of oversight hits.
If you want to expand your offering and explore validation on additional PCR test panels, reach out to John Castelino @ [email protected] for more information.
2
CLIA Goes Fully Digital. No Exceptions
As of March 1, 2026, CMS has moved CLIA to a fully paperless system.
Key implications:
- All certificates, notices, and fee communications are electronic
- Online payment is now mandatory
- Your email on file is now critical for compliance
If your contact information is not current, you are one missed message away from a compliance issue.
3
Medicare Cuts Avoided for 2026. But Do Not Relax
Labs avoided reimbursement cuts for 2026, but reporting requirements are back in focus.
What to know:
- No CLFS payment reductions this year
- Private payer data reporting window is May 1 through July 31, 2026
- Future cuts from 2027 through 2029 may reach up to 15 percent annually
This is your window to evaluate test profitability and optimize your test menu before pressure returns.
4
Measles Surge and H5N1 Monitoring Driving Testing Demand
Public health trends are shifting again.
- Measles cases are rising across multiple U.S. jurisdictions
- H5N1 surveillance continues to expand with commercial lab involvement
Why it matters:
- Increased demand for respiratory and infectious disease testing
- Greater importance of rapid turnaround and reporting
- Opportunity for labs with flexible molecular capabilities
Labs that can pivot quickly will capture both clinical and public health value.
If you want to explore validation and pricing on infectious disease panels, reach out to John Castelino @ [email protected] for more information.
Industry Events to Watch (April – July 2026)
Executive War College April 28 to April 29, 2026 | New Orleans, Louisiana
ADLM 2026 July 26 to July 30, 2026 | Anaheim, California
AMP Annual Meeting November 10 to November 14, 2026 | Seattle, Washington
If you are attending any of these events, let’s coordinate time to connect. Contact David Curley @ [email protected]
Quick Thought
The labs that will dominate the next 12 to 24 months will not just run strong assays.
They will combine regulatory discipline, financial awareness, operational agility, and high-quality data infrastructure.
That combination is what turns a lab into a strategic partner, not just a service provider.
Interesting Fact
Even small updates to CDC specimen submission protocols can significantly impact turnaround time, routing accuracy, and testing efficiency across lab networks.
Precision in operations is becoming just as important as precision in science.
Attending ADLM in July?
Want to meet more lab pros and network on us?
ADLM (formerly AACC) - July 26-30, Anaheim, CA. - ENDO will be hosting a networking Happy Hour at a nearby location (details will be released next month). Our networking events are ususally a big hit with the opportunity to meet other lab pros from around the Country, and potentially get some new ideas on what may be working for others.
We are all attempting to improve our businesses and we can learn from each other. We make networking easy while enjoying some cocktails and food.
Good food, good cocktails, good people, good ideas = business improvement opportunities
Please contact us if you plan to attend and we will reserve a spot for you.
email: [email protected] or [email protected]
Send us an email letting us know! [ [email protected], [email protected]]
Want to know more about ENDO Lab & Medical Systems’ capabilities and offerings?
ENDO Lab and Medical delivers innovative products and services that enable our customers to experience better patient outcomes, faster turn-around times, increased utilization of laboratory resources and improved profitability. Our industry expertise and personalized approach to service allows our customers to make informed decisions to grow revenue and protect their BOTTOM LINE.
Let's Engage and Learn More About Each Other
